The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases

Rationale: Patients with colorectal cancer die mainly due to liver metastases (CRC-LM). Although the tumor microenvironment (TME) plays an important role in tumor development and therapeutic response, our understanding of the individual TME components, especially cancer-associated fibroblasts (CAFs), remains limited. Methods: We analyzed CRC-LM CAFs and cancer cells by single-cell transcriptomics and used bioinformatics for data analysis and integration with related available single-cell and bulk transcriptomic datasets. We validated key findings by RT-qPCR, western blotting, and immunofluorescence. Results: By single-cell transcriptomic analysis of 4,397 CAFs from six CRC-LM samples, we identified two main CAF populations, contractile CAFs and extracellular matrix (ECM)-remodeling/pro-angiogenic CAFs, and four subpopulations with distinct phenotypes. We found that ECM-remodeling/pro-angiogenic CAFs derive from portal resident fibroblasts. They associate with areas of strong desmoplastic reaction and Wnt signaling in low-proliferating tumor cells engulfed in a stiff extracellular matrix. By integrating public single-cell primary liver tumor data, we propose a model to explain how different liver malignancies recruit CAFs of different origins to this organ. Lastly, we found that LTBP2 plays an important role in modulating collagen biosynthesis, ECM organization, and adhesion pathways. We developed fully human antibodies against LTBP2 that depleted LTBP2+ CAFs in vitro. Conclusion: This study complements recent reports on CRC-LM CAF heterogeneity at the single-cell resolution. The number of sequenced CAFs was more than one order of magnitude larger compared to existing data. LTBP2 targeting by antibodies might create opportunities to deplete ECM-remodeling CAFs in CRC-LMs. This might be combined with other therapies, e.g., anti-angiogenic compounds as already done in CRC. Moreover, we showed that in intrahepatic cholangiocarcinoma, in which ECM-remodeling CAF proportion is similar to that of CRC-LM, several genes expressed by ECM-remodeling CAFs, such as LTBP2, were associated with survival.

[1]  R. Zhao,et al.  Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer , 2022, Theranostics.

[2]  R. Schwabe,et al.  Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. , 2021, The Journal of clinical investigation.

[3]  Yinmo Yang,et al.  Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression , 2020, EBioMedicine.

[4]  I. Amit,et al.  A single cell atlas of the human liver tumor microenvironment , 2020, Molecular systems biology.

[5]  Hui-Yan Li,et al.  A Single-Cell Atlas of Liver Metastases of Colorectal Cancer Reveals the Reprogramming of the Tumor Microenvironment in Response to Preoperative Chemotherapy , 2020 .

[6]  D. Lambrechts,et al.  A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling , 2020, Cell Research.

[7]  T. Muley,et al.  Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer. , 2020, Cancer cell.

[8]  K. Tarte,et al.  Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. , 2020, Cancer discovery.

[9]  Jung-Il Lee,et al.  Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma , 2020, Nature Communications.

[10]  Jacques Colinge,et al.  SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics , 2019, bioRxiv.

[11]  Fabian J Theis,et al.  Generalizing RNA velocity to transient cell states through dynamical modeling , 2019, Nature Biotechnology.

[12]  Jonathan M. Hernandez,et al.  Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer. , 2019, Cancer cell.

[13]  C. Sautès-Fridman,et al.  Context-dependent roles of complement in cancer , 2019, Nature Reviews Cancer.

[14]  C. Ponting,et al.  Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.

[15]  P. Vermeulen,et al.  Histopathological growth patterns of colorectal liver metastasis exhibit little heterogeneity and can be determined with a high diagnostic accuracy , 2019, Clinical & Experimental Metastasis.

[16]  D. Brenner,et al.  The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma , 2019, International journal of molecular sciences.

[17]  J. Aparicio,et al.  SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018) , 2018, Clinical and Translational Oncology.

[18]  B. Bozóky,et al.  Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review , 2018, BMJ open gastroenterology.

[19]  Raghu Kalluri,et al.  A peek into cancer-associated fibroblasts: origins, functions and translational impact , 2018, Disease Models & Mechanisms.

[20]  Inna Kuperstein,et al.  Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. , 2018, Cancer cell.

[21]  D. Tougeron,et al.  Results and challenges of immune checkpoint inhibitors in colorectal cancer , 2018, Expert opinion on biological therapy.

[22]  A. Turtoi,et al.  Collaborative and Defensive Fibroblasts in Tumor Progression and Therapy Resistance. , 2017, Current Medicinal Chemistry.

[23]  G. G. Van den Eynden,et al.  Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases , 2016, Nature Medicine.

[24]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  T. Miyawaki,et al.  PDGFRα plays a crucial role in connective tissue remodeling , 2015, Scientific Reports.

[26]  Jeffrey S. Morris,et al.  The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.

[27]  R. Schwabe,et al.  Hepatic inflammation and fibrosis: Functional links and key pathways , 2015, Hepatology.

[28]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[29]  A. G. de Herreros,et al.  Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer , 2013, Clinical Cancer Research.

[30]  G. G. Van den Eynden,et al.  The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications. , 2013, Cancer research.

[31]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[32]  G. Sumara,et al.  Cross-talk between Insulin and Wnt Signaling in Preadipocytes , 2012, The Journal of Biological Chemistry.

[33]  Hong Peng,et al.  Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.

[34]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[35]  B. Imhof,et al.  Sushi repeat protein X‐linked 2, a novel mediator of angiogenesis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  A. Sonnenberg,et al.  Regulation of hemidesmosome disassembly by growth factor receptors. , 2008, Current opinion in cell biology.

[37]  Joshua D. Wythe,et al.  The netrin receptor UNC5B promotes angiogenesis in specific vascular beds , 2008, Development.

[38]  E. van Marck,et al.  Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia , 2004, British Journal of Cancer.

[39]  E. van Marck,et al.  Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia , 2001, The Journal of pathology.

[40]  A. Turtoi,et al.  Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes , 2018, Current opinion in oncology.

[41]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.